Private Sector Tatsuya Kondo Becomes PMDA Head
This article was originally published in PharmAsia News
Executive Summary
Japan's International Medical Center President Tatsuya Kondo became the new chief executive of Japan's Pharmaceuticals and Medical Devices Agency, effective April 1. Kondo is the first person to be appointed to the position who was not previously an administrative officer for Ministry of Health, Labor and Welfare. Kondo's immediate predecessor, former MHLW drug division director Akira Miyajima, resigned from the post on Jan. 17. His resignation is believed to be a sign of taking responsibility for ignoring a list of hepatitis C cases caused by contaminated blood products and failing to notify the patients about the information. (Click here for more - Japanese language